描述
Additional outcome measures from the IBS probiotic trial examine the interplay between anxiety, depression, and gut symptom severity. Results suggest that the probiotic combination may modulate both psychological and gastrointestinal dimensions of IBS.
Figure 4
ChartSource Paper
Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination.Cite This Figure
![Figure 4: Additional outcome measures from the IBS probiotic trial examine the interplay between anxiety, depression, and gut symptom severity. Results suggest that the probiotic combination may modulate both psychological and gastrointestinal dimensions of IBS.]() > Source: David Groeger et al. "Interactions between symptoms and psychological status in irritable bowel syndro." *Neurogastroenterology and motility*, 2023. PMID: [36178333](https://pubmed.ncbi.nlm.nih.gov/36178333/)
<figure> <img src="" alt="Additional outcome measures from the IBS probiotic trial examine the interplay between anxiety, depression, and gut symptom severity. Results suggest that the probiotic combination may modulate both psychological and gastrointestinal dimensions of IBS." /> <figcaption>Figure 4. Additional outcome measures from the IBS probiotic trial examine the interplay between anxiety, depression, and gut symptom severity. Results suggest that the probiotic combination may modulate both psychological and gastrointestinal dimensions of IBS.<br> Source: David Groeger et al. "Interactions between symptoms and psychological status in irritable bowel syndro." <em>Neurogastroenterology and motility</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36178333/">36178333</a></figcaption> </figure>